Delivery Order SPE2DB20D1109-SPE2DB24FP58B

Award Date 7/25/24
Potential Completion Date 7/26/24
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Erythromycin 0.5% eye ointment, 3.5 grams, with a ceiling value of $1,017.23. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026....
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,820,348 units of Erythromycin 0.5% Eye Ointment in 3.5 gram containers, with a ceiling value of $3,110.58 and a performance period ending on January 3, 2025. This order is not designated as a set-aside contract. Amerisourcebergen holds a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,188.80 firm fixed price delivery order is for the supply of 4565427156 - Erythromycin 0.5% Eye Ointment 3.5GM, with a completion date of August 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Erythromycin 0.5% Eye Ointment in 3.5 gram tubes, with a ceiling value of $1,833.23 and a completion date of December 12, 2024. The contract is a firm fixed-price, non-set-aside award. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,564.03, is for the delivery of 4563650955 - Erythromycin 0.5% Eye Ointment, 3.5 gm. The contract has a completion date of February 14, 2024 and is a firm fixed-price, delivery order contract. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite...
This federal contract award is for the delivery of 4,566,765,471 units of Erythromycin 0.5% Eye Ointment in 3.5 gram containers. The award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 19, 2024 with a completion date of December 20, 2024. The contract has a firm fixed price of $6,296.24 and was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency that supports military healthcare...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of Erythromycin 0.5% eye ointment with a potential value of $1,281.36 and a performance period through March 6, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) awarded...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The order is for the supply of Erythromycin 0.5% eye ointment, a pharmaceutical product, with a ceiling value of $1,174.73 and a period of performance through March 29, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor on this delivery order and is also the prime...
This federal contract award is for the delivery of Erythromycin 0.5% eye ointment, with a ceiling value of $3,140.46. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of May 29, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566338491 - Erythromycin 0.5% Eye Ointment, 3.5 grams, with a ceiling value of $1,526.92. The contract is a firm fixed-price, delivery order contract with a period of performance through November 6, 2024. Amerisourcebergen is a for-profit organization...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB24FP58B
    Delivery Order

This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4565253700 - Erythromycin 0.5% Eye Ointment, with a ceiling value of $2,307.34 and a completion date of July 26, 2024. This appears to be a delivery order placed under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific contract award was not designated with a set-aside requirement, indicating open competition.

Generated 2/27/25, 11:33 AM